Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Pleural Disorders: Types and Brief Description

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:

Pleural Effusion II: Symptoms and Management

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Targeting KRAS for cancer therapy.

British journal of pharmacology·2026

Same author

A Massive Cavernous Mediastinal Haemangioma Causing Superior Vena Cava Obstruction and Extending to the Supraclavicular Space: A Case Report.

Cureus·2026

Same author

PA200 differentially regulates the proteasome and inhibits migration of NSCLC cells.

Journal of cell science·2026

Same author

Pyrimidine addiction: an Achilles' heel of NF2-altered mesothelioma.

EMBO molecular medicine·2025

Same author

Improved survival of patients with stage III small-cell lung cancer with primary resection: A SEER-based analysis.

Translational oncology·2024

Same author

Clinical identification of malignant pleural effusions.

Translational oncology·2023

Search research articles

Related Experiment Video

Updated: Jun 7, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Translational advances in pleural malignancies.

Georgios T Stathopoulos¹

¹Department of Physiology, School of Medicine, University of Patras, Rio, Greece. gstathop@upatras.gr

Respirology (Carlton, Vic.)

|November 4, 2010

Summary

Recent advances in pleural malignancy research, including mesothelioma, offer new treatments and diagnostic tools. Further research into tumor progression and dedicated clinical studies are crucial for improving patient outcomes in malignant pleural diseases.

Area of Science:

Oncology
Translational Research

Background:

Pleural malignancies, such as malignant pleural mesothelioma and secondary pleural metastasis causing malignant pleural effusion, are significant causes of cancer-related mortality.
Despite their lethality, dedicated translational research efforts are essential for clinical advancements.

Purpose of the Study:

To review recent clinical advances in pleural malignancies based on preclinical research.
To highlight emerging research findings expected to impact future clinical practice in pleural oncology.
To outline key obstacles hindering translational research in pleural malignancies.

Main Methods:

Review of established and emerging translational research findings in pleural malignancies.
Discussion of preclinical models, including genetic mouse models and transplantable models in immunocompetent hosts.

More Related Videos

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

Related Experiment Videos

Last Updated: Jun 7, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

Examination of stereological and imaging methods for assessing pleural tumor burden.

Main Results:

Established clinical advances include folate antimetabolites for mesothelioma, PET imaging, and mesothelin as a diagnostic marker.
Emerging research indicates therapeutic potential for aminobiphosphonates, histone deacetylase inhibitors, and ribonucleases.
Development of novel preclinical models and assessment tools for pleural malignancies.

Conclusions:

Significant progress has been made in understanding and treating pleural malignancies.
Overcoming obstacles such as dissecting tumor progression pathways and establishing dedicated research consortia is vital.
Separate clinical and preclinical study of mesothelioma and malignant pleural effusion is necessary for focused advancement.